ACM
PFE icon

Ativo Capital Management’s Pfizer PFE Stock Holding History

Ativo Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-25,208
Closed -$1.32M – 111
2022
Q2 		$1.32M Buy
+25,208
New +$1.28M 0.89% 30
2020
Q1 		– Sell
-22,065
Closed -$820K – 113
2019
Q4 		$820K Sell
22,065
-13,563
-38% -$483K 0.38% 89
2019
Q3 		$1.22M Sell
35,628
-8,092
-19% -$294K 0.59% 60
2019
Q2 		$1.8M Sell
43,720
-7,328
-14% -$291K 0.81% 39
2019
Q1 		$2.06M Sell
51,048
-3,149
-6% -$126K 0.86% 36
2018
Q4 		$2.24M Sell
54,197
-16,256
-23% -$675K 1.05% 17
2018
Q3 		$2.95M Buy
70,453
+110
+0.2% +$4.24K 0.79% 15
2018
Q2 		$2.42M Sell
70,343
-2,003
-3% -$68.4K 0.67% 31
2018
Q1 		$2.44M Buy
72,346
+242
+0.3% +$8.32K 0.69% 31
2017
Q4 		$2.48M Buy
72,104
+5,113
+8% +$174K 0.66% 25
2017
Q3 		$2.27M Buy
66,991
+2,307
+4% +$74.1K 0.61% 45
2017
Q2 		$2.06M Sell
64,684
-5,372
-8% -$169K 0.56% 56
2017
Q1 		$2.27M Sell
70,056
-27,075
-28% -$854K 0.56% 44
2016
Q4 		$2.99M Sell
97,131
-6
-0% -$183 0.71% 33
2016
Q3 		$3.12M Sell
97,137
-4,481
-4% -$150K 0.72% 36
2016
Q2 		$3.4M Sell
101,618
-6,431
-6% -$205K 0.83% 24
2016
Q1 		$3.04M Sell
108,049
-330
-0.3% -$9.43K 0.82% 37
2015
Q4 		$3.32M Buy
108,379
+4,219
+4% +$133K 0.83% 30
2015
Q3 		$3.31M Buy
104,160
+42,225
+68% +$1.35M 0.88% 34
2015
Q2 		$2.07M Sell
61,935
-4,870
-7% -$159K 0.73% 45
2015
Q1 		$2.21M Buy
66,805
+15,614
+31% +$496K 0.86% 29
2014
Q4 		$1.51M Sell
51,191
-49,864
-49% -$1.43M 0.62% 59
2014
Q3 		$2.83M Sell
101,055
-16,059
-14% -$451K 1.12% 30
2014
Q2 		$3.3M Sell
117,114
-1,383
-1% -$39.4K 1.43% 22
2014
Q1 		$3.61M Sell
118,497
-10,956
-8% -$327K 1.46% 12
2013
Q4 		$3.76M Sell
129,453
-7,406
-5% -$216K 1.65% 7
2013
Q3 		$3.73M Buy
136,859
+11,787
+9% +$321K 1.77% 7
2013
Q2 		$3.32M Buy
+125,072
New +$3.46M 1.72% 7

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ativo Capital Management's PFE Position: Q3 2022 in Review

Ativo Capital Management sold out of Pfizer (PFE) in Q3 2022, closing a stake of 25,208 shares — an estimated $1.32M sold.

Ativo Capital Management first reported a position in PFE in Q2 2013 and held it in 28 quarters. The position peaked at $3.76M in Q4 2013. 3,088 funds tracked by Wall St. Rank hold PFE as of Q3 2022.

  • Ativo Capital Management reported no remaining Pfizer position as of Q3 2022 after selling out during the quarter.
  • Ativo Capital Management sold 25,208 Pfizer shares in Q3 2022, an estimated $1.32M.
  • Ativo Capital Management first reported a position in Pfizer in Q2 2013 and held it in 28 quarters.
  • Ativo Capital Management's Pfizer position peaked at $3.76M in Q4 2013.
  • 3,088 funds tracked by Wall St. Rank held Pfizer as of Q3 2022.

Based on Ativo Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.